Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Caribou Biosciences Analyst Ratings
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
Agilent Technologies Analyst Ratings
Agilent Technologies, Inc. (A) Q4 2024 Earnings Call Transcript Summary
Agilent Technologies Sees Q1 Adj. EPS $1.25-$1.28 Vs $1.37 Est.; Revenue $1.65B-$1.68B Vs $1.697B Est.
Vertex Leads J.P. Morgan's Top Biotech Picks List for 2025